| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
7 companies
Patrick G Enright is Director, 10% Owner at MANE and has filed Form 4s across 7 companies. From March 2015 to August 2026, the filings on record show 9 open-market purchases and 22 sales. Patrick G Enright's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $301.5M at current prices.
Historically, Patrick G Enright's trades have earned a strong insider score of 71/100 across 13 rated trades. Over a 12-month horizon, 70.0% of those trades were profitable, with an average 12-month return of +11.7%.
The biggest single holding is MANE (~$274.4M) as Director, 10% Owner. Net of sales, the MANE filings show accumulation of 1,075,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | VERA Vera Therapeutics, Inc. | Director, 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +10.8% | -14.9% | -58.0% | |
| May 18, 2021 | VERA Vera Therapeutics, Inc. | Director, 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +41.6% | +37.7% | +32.9% | |
| Nov 12, 2020 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 9,929 | $146.72 | $1,456,738.14 | -32.8% | - | - | |
| Aug 9, 2019 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 726 | $135.65 | $98,481.10 | -3.9% | - | - | |
| Sep 6, 2018 | JAZZ Jazz Pharmaceuticals Plc | Director | Sale+OE | 10,130 | $168.76 | $1,709,564.68 | -38.1% | - | - | |
| Aug 10, 2018 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 1,365 | $175.13 | $239,057.09 | -7.7% | - | - | |
| Dec 11, 2017 | JAZZ Jazz Pharmaceuticals Plc | Director | Sale+OE | 9,000 | $139.73 | $1,257,581.52 | -35.5% | - | - | |
| Nov 17, 2017 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 352 | $133.19 | $46,882.88 | -20.5% | - | - | |
| Aug 25, 2017 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 351 | $148.40 | $52,088.40 | -17.0% | - | - | |
| Aug 11, 2017 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 662 | $142.37 | $94,247.63 | -24.2% | - | - |